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SHARE: a milestone in joint programming for HIV and 
intimate partner violence
Intimate partner violence is highly prevalent in sub-
Saharan Africa and its role in increasing women’s risk 
of HIV acquisition is well recognised, although many 
aspects of the mechanisms through which HIV increases 
women’s risk remain unclear.1–3 The most important 
challenge for researchers is to develop combination 
interventions that eﬀ ectively reduce both the risk of HIV 
acquisition and the risk of intimate partner violence. 
Thus far there have been key trials in South Africa with 
the Stepping Stones4 intervention and the IMAGES 
study,5 which combine microﬁ nance and a gender 
intervention. However, both interventions reduced 
intimate partner violence but had no eﬀ ect on HIV 
acquisition. In The Lancet Global Health, Jennifer Wagman 
and colleagues6 report ﬁ ndings of their SHARE study in 
Rakai, Uganda—the ﬁ rst behavioural intervention to 
reduce both HIV incidence and intimate partner violence 
reported in women.
SHARE is a multi-component intervention that involves 
mainly community action to change of social norms 
that support violence and to provide enhanced HIV 
counselling, including information on intimate partner 
violence and safety for women who test positive for 
HIV. It has been hypothesised that community-wide 
interventions that focus on social norm change are an 
important next direction for prevention of violence 
against women because, by deﬁ nition, they intervene 
upstream and are positioned to change the conditions 
that might undermine sustainability of impact. An 
assessment of Sasa!, a similar intervention in Uganda, 
did not show signiﬁ cant eﬀ ect on physical intimate 
partner violence, but this ﬁ nding was probably because 
of insuﬃ  cient power.7 Wagman and colleagues’6 
ﬁ ndings provide important support for an intervention 
model. Although social norm change was not the 
only component of SHARE and the eﬀ ect of enhanced 
counselling on women’s risk of intimate partner 
violence is not known, it is hard to imagine that it was 
an important driver of the main ﬁ nding given that only 
56 women in the intervention communities in the study 
had seroconverted and so might have been using services.
The intervention did not have a signiﬁ cant eﬀ ect on 
self-reported male perpetration of intimate partner 
violence. Men could have been less honest in their 
disclosure of perpetration than were women, and this 
diﬀ erence might have made their reports unreliable 
as an outcome. However, previous population-based 
studies generally note that women’s reports of intimate 
partner violence tend to be the same as men or lower in 
prevalence than men’s of perpetration, but perhaps what 
is seen here is a trial eﬀ ect.8 Assessments of interventions 
against violence have an inherent weakness in that 
biological measures do not exist to valuate self-reports. 
In view of the stressfull eﬀ ect of home exposure to 
violence, a future development in the assessment of 
interventions against intimate partner violence should 
include biological markers of stress, (eg, cortisol) as an 
indicator of eﬀ ect.
Compared with individuals in control clusters given 
only standard HIV services, individuals in the SHARE 
intervention groups reported signiﬁ cantly less past-year 
physical (346 [16%] vs 217 [12%] in intervention groups; 
adjusted prevalence risk ratio 0·79, 95% CI 0·67–0·92) 
and sexual (261 [13%] vs 167 [10%]; 0·80, 0·67–0·97) 
intimate partner violence after 24 months. Findings 
were not signiﬁ cant at 12 months (follow-up 1). These 
ﬁ ndings support those of Stepping Stones Study4 and 
IMAGE trial,5 both of which show that the eﬀ ects of 
major interventions evolve with interventions rather 
than attenuate. This diﬀ erence shows the need for 
researchers and donors to be mindful of the need 
for longer term follow-up in these trials to avoid 
prematurely negative ﬁ ndings.
The evidence base for prevention interventions for 
intimate partner violence and dual programming to 
reduce HIV acquisition in sub-Saharan Africa is still 
very small. Assessments need to be replicated and 
translation research carried out into the conditions 
and inputs required to scale-up eﬀ ects, and its cost and 
eﬀ ectiveness. To advance, the specialty needs injections 
of donor funds to replicate proven interventions and 
increase evidence. In this regard, the Department for 
International Development global programme What 
Works to Prevent Violence Against Women and Girls could 
escalate the science of prevention of intimate partner 
violence and evidence of intervention outcomes in 
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several regions worldwide. However, substantially 
more large-scale and long-term investment is needed 
to advance towards a goal of ending violence against 
women and girls. 
Rachel K Jewkes
Medical Research Council, Pretoria 0001, South Africa
rjewkes@mrc.ac.za
I am supported by the Medical Research Council of South Africa and have 
received funding from Department for International Development (DFID). This 
Comment is output from the What Works to Prevent Violence: a Global 
Programme, which is funded by UK Aid from the DFID.  The views expressed and 
information contained in it are not necessarily those of or endorsed by DFID, 
which can accept no responsibility for such views or information or for any 
reliance placed on them.
Copyright © Jewkes. Open Access article distributed under the terms of 
CC BY-NC-ND
1 Devries KM, Mak JY, Garcia-Moreno C, Petzold M, Child JC, et al. Global 
health. The global prevalence of intimate partner violence against women. 
Science 2013; 340: 1527–28.
2 Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, 
relationship gender power inequity, and incidence of HIV infection in 
young women in South Africa: a cohort study. Lancet 2010; 367: 41–48.
3 WHO. Global and regional estimates of violence against women: 
prevalence and health eﬀ ects of intimate partner violence and non-partner 
sexual violence. Geneva: World Health Organisation, 2013.
4 Jewkes R, Nduna M, Levin J, et al. Impact of Stepping Stones on incidence 
of HIV, HSV-2 and sexual behaviour in rural South Africa: cluster 
randomised controlled trial. BMJ 2008; 337: a506.
5 Pronyk P, Hargreaves JR, Kim JC, et al. Eﬀ ect of a structural intervention for 
the prevention of intimate partner violence and HIV in rural South Africa: 
a cluster randomised trial. Lancet 2006; 368: 1973–83.
6 Wagman JA, Gray RH, Campbell JC, et al. Eﬀ ectiveness of an integrated 
intimate partner violence and HIV prevention intervention in Rakai, 
Uganda: analysis of an intervention in an existing cluster randomised 
cohort. Lancet Glob Health 2014; 3: e23–33.
7 Abramsky T, Devries K, Kiss L, et al. Findings from the SASA! Study: a cluster 
randomized controlled trial to assess the impact of a community 
mobilization intervention to prevent violence against women and reduce 
HIV risk in Kampala, Uganda. BMC Med 2014; 12: 122.
8 Fulu E, Warner X, Miedema S, et al. Why do some men use violence against 
women and how can we prevent it. Bangkok: UN Development 
Programme, UN Population Fund, UN Women, UN Volunteers, 2013. 
